The medical community is buzzing by retatrutide, a new dual GIP and GLP-1 receptor that’s showing significant results in preliminary studies . This treatment works by mimicking natural hormones to affect appetite and increase feelings of satiety, ultimately resulting in noticeable body reduction . While still under investigation and not yet avai… Read More